241 related articles for article (PubMed ID: 22452635)
21. Survival predictors in patients with prostate adenocarcinoma with hormonal blockade.
Angulo JC; Redondo C; Sánchez-Chapado M; Colás B; Ropero S; López JI
Pathol Res Pract; 2016 Oct; 212(10):899-903. PubMed ID: 27502465
[TBL] [Abstract][Full Text] [Related]
22. MUC-1 gene is associated with prostate cancer death: a 20-year follow-up of a population-based study in Sweden.
Andrén O; Fall K; Andersson SO; Rubin MA; Bismar TA; Karlsson M; Johansson JE; Mucci LA
Br J Cancer; 2007 Sep; 97(6):730-4. PubMed ID: 17726465
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of Ki67 in localized prostate carcinoma: a multi-institutional study of >1000 prostatectomies.
Tretiakova MS; Wei W; Boyer HD; Newcomb LF; Hawley S; Auman H; Vakar-Lopez F; McKenney JK; Fazli L; Simko J; Troyer DA; Hurtado-Coll A; Thompson IM; Carroll PR; Ellis WJ; Gleave ME; Nelson PS; Lin DW; True LD; Feng Z; Brooks JD
Prostate Cancer Prostatic Dis; 2016 Sep; 19(3):264-70. PubMed ID: 27136741
[TBL] [Abstract][Full Text] [Related]
24. ERG protein expression reflects hormonal treatment response and is associated with Gleason score and prostate cancer specific mortality.
Bismar TA; Dolph M; Teng LH; Liu S; Donnelly B
Eur J Cancer; 2012 Mar; 48(4):538-46. PubMed ID: 22300588
[TBL] [Abstract][Full Text] [Related]
25. A negative confirmatory biopsy among men on active surveillance for prostate cancer does not protect them from histologic grade progression.
Wong LM; Alibhai SM; Trottier G; Timilshina N; Van der Kwast T; Zlotta A; Lawrentschuk N; Kulkarni G; Hamilton R; Ferrara S; Margel D; Trachtenberg J; Jewett MA; Toi A; Evans A; Fleshner NE; Finelli A
Eur Urol; 2014 Sep; 66(3):406-13. PubMed ID: 23664820
[TBL] [Abstract][Full Text] [Related]
26. DNA-PKcs expression predicts response to radiotherapy in prostate cancer.
Bouchaert P; Guerif S; Debiais C; Irani J; Fromont G
Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):1179-85. PubMed ID: 22494583
[TBL] [Abstract][Full Text] [Related]
27. Biopsy tissue microarray study of Ki-67 expression in untreated, localized prostate cancer managed by active surveillance.
Jhavar S; Bartlett J; Kovacs G; Corbishley C; Dearnaley D; Eeles R; Khoo V; Huddart R; Horwich A; Thompson A; Norman A; Brewer D; Cooper CS; Parker C
Prostate Cancer Prostatic Dis; 2009; 12(2):143-7. PubMed ID: 18762814
[TBL] [Abstract][Full Text] [Related]
28. Prognostic value of PTEN loss in men with conservatively managed localised prostate cancer.
Cuzick J; Yang ZH; Fisher G; Tikishvili E; Stone S; Lanchbury JS; Camacho N; Merson S; Brewer D; Cooper CS; Clark J; Berney DM; Møller H; Scardino P; Sangale Z;
Br J Cancer; 2013 Jun; 108(12):2582-9. PubMed ID: 23695019
[TBL] [Abstract][Full Text] [Related]
29. Prostate cancer Ki-67 (MIB-1) expression, perineural invasion, and gleason score as biopsy-based predictors of prostate cancer mortality: the Mayo model.
Tollefson MK; Karnes RJ; Kwon ED; Lohse CM; Rangel LJ; Mynderse LA; Cheville JC; Sebo TJ
Mayo Clin Proc; 2014 Mar; 89(3):308-18. PubMed ID: 24486077
[TBL] [Abstract][Full Text] [Related]
30. Prognostic and predictive significance of proliferation in 867 colorectal cancers.
Fodor IK; Hutchins GG; Espiritu C; Quirke P; Jubb AM
J Clin Pathol; 2012 Nov; 65(11):989-95. PubMed ID: 22859394
[TBL] [Abstract][Full Text] [Related]
31. Biopsy features associated with prostate cancer progression in active surveillance patients: comparison of three statistical models.
Iremashvili V; Manoharan M; Rosenberg DL; Soloway MS
BJU Int; 2013 Apr; 111(4):574-9. PubMed ID: 22564446
[TBL] [Abstract][Full Text] [Related]
32. [Relevance of Endoglin (CD105) VEGF and p53 with invasion metastasis and prognosis of laryngeal carcinoma].
Li Q; Zhang B; Peng P
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Dec; 21(24):1114-7. PubMed ID: 18330257
[TBL] [Abstract][Full Text] [Related]
33. Ki-67 staining is an independent correlate of biochemical failure in prostate cancer treated with radiotherapy.
Cowen D; Troncoso P; Khoo VS; Zagars GK; von Eschenbach AC; Meistrich ML; Pollack A
Clin Cancer Res; 2002 May; 8(5):1148-54. PubMed ID: 12006531
[TBL] [Abstract][Full Text] [Related]
34. Gleason inflation 1998-2011: a registry study of 97,168 men.
Danneman D; Drevin L; Robinson D; Stattin P; Egevad L
BJU Int; 2015 Feb; 115(2):248-55. PubMed ID: 24552193
[TBL] [Abstract][Full Text] [Related]
35. Role of co-expression of estrogen receptor beta and Ki67 in prostate adenocarcinoma.
Azizan N; Hayati F; Tizen NMS; Farouk WI; Masir N
Investig Clin Urol; 2018 Jul; 59(4):232-237. PubMed ID: 29984337
[TBL] [Abstract][Full Text] [Related]
36. Predictors of pathological progression among men with localized prostate cancer undergoing active surveillance: a sub-analysis of the REDEEM study.
Margel D; Nandy I; Wilson TH; Castro R; Fleshner N
J Urol; 2013 Dec; 190(6):2039-45. PubMed ID: 23820059
[TBL] [Abstract][Full Text] [Related]
37. KI67 and DLX2 predict increased risk of metastasis formation in prostate cancer-a targeted molecular approach.
Green WJ; Ball G; Hulman G; Johnson C; Van Schalwyk G; Ratan HL; Soria D; Garibaldi JM; Parkinson R; Hulman J; Rees R; Powe DG
Br J Cancer; 2016 Jul; 115(2):236-42. PubMed ID: 27336609
[TBL] [Abstract][Full Text] [Related]
38. How much does Gleason grade of follow-up biopsy differ from that of initial biopsy in untreated, Gleason score 4-7, clinically localized prostate cancer?
Choo R; Danjoux C; Morton G; Szumacher E; Sugar L; Gardner S; Kim M; Choo CM; Klotz L
Prostate; 2007 Nov; 67(15):1614-20. PubMed ID: 17823923
[TBL] [Abstract][Full Text] [Related]
39. Whole-mount prostate sections reveal differential endoglin expression in stromal, epithelial, and endothelial cells with the development of prostate cancer.
Kassouf W; Ismail HR; Aprikian AG; Chevalier S
Prostate Cancer Prostatic Dis; 2004; 7(2):105-10. PubMed ID: 15175661
[TBL] [Abstract][Full Text] [Related]
40. Low levels of phosphorylated epidermal growth factor receptor in nonmalignant and malignant prostate tissue predict favorable outcome in prostate cancer patients.
Hammarsten P; Karalija A; Josefsson A; Rudolfsson SH; Wikström P; Egevad L; Granfors T; Stattin P; Bergh A
Clin Cancer Res; 2010 Feb; 16(4):1245-55. PubMed ID: 20145160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
